Literature DB >> 20547749

Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation.

Joshua D Stender1, Kyuri Kim, Tze Howe Charn, Barry Komm, Ken C N Chang, W Lee Kraus, Christopher Benner, Christopher K Glass, Benita S Katzenellenbogen.   

Abstract

Nuclear receptor estrogen receptor alpha (ER alpha) controls the expression of hundreds of genes responsible for target cell phenotypic properties, but the relative importance of direct versus tethering mechanisms of DNA binding has not been established. In this first report, we examine the genome-wide chromatin localization of an altered-specificity mutant ER with a DNA binding domain deficient in binding to estrogen response element (ERE)-containing DNA (DBDmut ER) versus wild-type ER alpha. Using high-throughput sequencing of ER chromatin immunoprecipitations (ChIP-Seq) and mRNA transcriptional profiling, we show that direct ERE binding is required for most of (75%) estrogen-dependent gene regulation and 90% of hormone-dependent recruitment of ER to genomic binding sites. De novo motif analysis of the chromatin binding regions in MDA-MB-231 human breast cancer cells defined unique transcription factor profiles responsible for genes regulated through tethering versus direct ERE binding, with Runx motifs enriched in ER-tethered sites. We confirmed a role for Runx1 in mediating ER alpha genomic recruitment and regulation of tethering genes. Our findings delineate the contributions of direct receptor ERE binding versus binding through response elements for other transcription factors in chromatin localization and ER-dependent gene regulation, paradigms likely to underlie the gene regulatory actions of other nuclear receptors as well.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20547749      PMCID: PMC2916448          DOI: 10.1128/MCB.00118-10

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

Review 1.  The multifaceted mechanisms of estradiol and estrogen receptor signaling.

Authors:  J M Hall; J F Couse; K S Korach
Journal:  J Biol Chem       Date:  2001-07-17       Impact factor: 5.157

Review 2.  Diversity in the mechanisms of gene regulation by estrogen receptors.

Authors:  Rocio Sanchez; Denis Nguyen; Walter Rocha; John H White; Sylvie Mader
Journal:  Bioessays       Date:  2002-03       Impact factor: 4.345

Review 3.  Combinatorial control of gene expression by nuclear receptors and coregulators.

Authors:  Neil J McKenna; Bert W O'Malley
Journal:  Cell       Date:  2002-02-22       Impact factor: 41.582

Review 4.  Estrogen receptor pathways to AP-1.

Authors:  P J Kushner; D A Agard; G L Greene; T S Scanlan; A K Shiau; R M Uht; P Webb
Journal:  J Steroid Biochem Mol Biol       Date:  2000-11-30       Impact factor: 4.292

5.  Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements.

Authors:  B Saville; M Wormke; F Wang; T Nguyen; E Enmark; G Kuiper; J A Gustafsson; S Safe
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

6.  Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

Authors:  Y Shang; X Hu; J DiRenzo; M A Lazar; M Brown
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

Review 7.  Estrogen receptor interaction with estrogen response elements.

Authors:  C M Klinge
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

8.  Long-range chromatin regulatory interactions in vivo.

Authors:  David Carter; Lyubomira Chakalova; Cameron S Osborne; Yan-feng Dai; Peter Fraser
Journal:  Nat Genet       Date:  2002-11-11       Impact factor: 38.330

Review 9.  Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions.

Authors:  S Safe
Journal:  Vitam Horm       Date:  2001       Impact factor: 3.421

10.  Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells.

Authors:  Chin-Yo Lin; Anders Ström; Vinsensius Berlian Vega; Say Li Kong; Ai Li Yeo; Jane S Thomsen; Wan Ching Chan; Balraj Doray; Dhinoth K Bangarusamy; Adaikalavan Ramasamy; Liza A Vergara; Suisheng Tang; Allen Chong; Vladimir B Bajic; Lance D Miller; Jan-Ake Gustafsson; Edison T Liu
Journal:  Genome Biol       Date:  2004-08-12       Impact factor: 13.583

View more
  103 in total

Review 1.  RUNX1-dependent mechanisms in biological control and dysregulation in cancer.

Authors:  Deli Hong; Andrew J Fritz; Jonathan A Gordon; Coralee E Tye; Joseph R Boyd; Kirsten M Tracy; Seth E Frietze; Frances E Carr; Jeffrey A Nickerson; Andre J Van Wijnen; Anthony N Imbalzano; Sayyed K Zaidi; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  J Cell Physiol       Date:  2018-12-04       Impact factor: 6.384

Review 2.  The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer.

Authors:  Donald P McDonnell; Suzanne E Wardell
Journal:  Curr Opin Pharmacol       Date:  2010-12       Impact factor: 5.547

3.  Opposing effects of Runx2 and estradiol on breast cancer cell proliferation: in vitro identification of reciprocally regulated gene signature related to clinical letrozole responsiveness.

Authors:  Nyam-Osor Chimge; Sanjeev K Baniwal; Jingqin Luo; Simon Coetzee; Omar Khalid; Benjamin P Berman; Debu Tripathy; Matthew J Ellis; Baruch Frenkel
Journal:  Clin Cancer Res       Date:  2011-12-06       Impact factor: 12.531

4.  Binding site specificity and factor redundancy in activator protein-1-driven human papillomavirus chromatin-dependent transcription.

Authors:  Wei-Ming Wang; Shwu-Yuan Wu; A-Young Lee; Cheng-Ming Chiang
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

5.  TIP: a probabilistic method for identifying transcription factor target genes from ChIP-seq binding profiles.

Authors:  Chao Cheng; Renqiang Min; Mark Gerstein
Journal:  Bioinformatics       Date:  2011-10-29       Impact factor: 6.937

6.  Activation of estrogen receptor α by raloxifene through an activating protein-1-dependent tethering mechanism in human cervical epithelial cancer cells: a role for c-Jun N-terminal kinase.

Authors:  Elizabeth A Fogarty; Christina K Matulis; W Lee Kraus
Journal:  Mol Cell Endocrinol       Date:  2011-09-22       Impact factor: 4.102

7.  Thyroid Hormone Receptor β Inhibits Self-Renewal Capacity of Breast Cancer Stem Cells.

Authors:  Irene López-Mateo; Elvira Alonso-Merino; Cristian Suarez-Cabrera; Jeong Won Park; Sheue-Yann Cheng; Susana Alemany; Jesús M Paramio; Ana Aranda
Journal:  Thyroid       Date:  2019-12-30       Impact factor: 6.568

8.  Prediction of regulatory motifs from human Chip-sequencing data using a deep learning framework.

Authors:  Jinyu Yang; Anjun Ma; Adam D Hoppe; Cankun Wang; Yang Li; Chi Zhang; Yan Wang; Bingqiang Liu; Qin Ma
Journal:  Nucleic Acids Res       Date:  2019-09-05       Impact factor: 16.971

9.  A MicroRNA196a2* and TP63 circuit regulated by estrogen receptor-α and ERK2 that controls breast cancer proliferation and invasiveness properties.

Authors:  Kyuri Kim; Zeynep Madak-Erdogan; Rosa Ventrella; Benita S Katzenellenbogen
Journal:  Horm Cancer       Date:  2012-12-19       Impact factor: 3.869

10.  The Phosphorylated Estrogen Receptor α (ER) Cistrome Identifies a Subset of Active Enhancers Enriched for Direct ER-DNA Binding and the Transcription Factor GRHL2.

Authors:  Kyle T Helzer; Mary Szatkowski Ozers; Mark B Meyer; Nancy A Benkusky; Natalia Solodin; Rebecca M Reese; Christopher L Warren; J Wesley Pike; Elaine T Alarid
Journal:  Mol Cell Biol       Date:  2019-01-16       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.